| P50 | author | Karel Pacak | Q64821278 |
| P2093 | author name string | John C Morris | |
| | Raj K Puri | |
| | Lucia Martiniova | |
| | Irina A Lubensky | |
| | Ronald R de Krijger | |
| | Bharat H Joshi | |
| | Toshio Fujisawa | |
| | Abdel G Elkahloun | |
| | Edwin W Lai | |
| | Pamela Leland | |
| | Ritika Dogra | |
| P2860 | cites work | The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor | Q71968340 |
| | Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy | Q81317022 |
| | Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy | Q28257229 |
| | IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis | Q28285105 |
| | Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma | Q34142563 |
| | Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside | Q35597936 |
| | Improved anti-tumor activity and safety of interleukin-13 receptor targeted cytotoxin by systemic continuous administration in head and neck cancer xenograft model. | Q36088101 |
| | Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas | Q36467140 |
| | Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy | Q36478656 |
| | Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases | Q36617133 |
| | An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges | Q36652761 |
| | Clinical review: Current treatment of malignant pheochromocytoma | Q36729834 |
| | Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin. | Q38288231 |
| | Evidence that IL-13R alpha2 chain in human glioma cells is responsible for the antitumor activity mediated by receptor-directed cytotoxin therapy | Q38327826 |
| | Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coli. | Q40473122 |
| | Specifically targeted killing of interleukin-13 (IL-13) receptor-expressing breast cancer by IL-13 fusion cytotoxin in animal model of human disease. | Q40585494 |
| | Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway | Q41011905 |
| | Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells | Q41090719 |
| | Gene expression profiling of benign and malignant pheochromocytoma | Q41443242 |
| | Interleukin-13 receptor as a unique target for anti-glioblastoma therapy | Q43567315 |
| | Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor alpha2 chain in vivo | Q45862963 |
| | Conditional Pten knock-out mice: a model for metastatic phaeochromocytoma | Q46163793 |
| | Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group | Q46232239 |
| | Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice. | Q52826566 |
| | ErbB-2 induces bilateral adrenal pheochromocytoma formation in mice. | Q53536726 |
| | Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas. | Q55475919 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| | phaeochromocytoma | Q536269 |
| | malignant pheochromocytoma | Q60195344 |
| | overexpression | Q61643320 |
| P304 | page(s) | 2952-2957 | |
| P577 | publication date | 2009-06-02 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy | |
| P478 | volume | 94 | |